First Mediterranean Thematic Workshop on Advanced Molecular Brain Imaging with Compact High Performance MRI-Compatible PET and SPECT Imagers – Potential for a Paradigm Shift

Home

First Mediterranean Thematic Workshop on Advanced Molecular Brain Imaging with Compact High Performance MRI Compatible PET and SPECT Imagers - Potential for a Paradigm Shift 1,2  September  2012 Giardini di Naxos (Taormina, Sicily,Italy)   And the adjunct satellite technical meeting the Latest Enabling Technological Breakthroughs in Compact Radiation Sensors, Electronics and Software for PET ad SPECT:  30,31 August  2012 Giardini di Naxos (Taormina, Sicily,Italy)
The purpose of this two-part workshop, planned for August 30-September 2, 2012 in Giardini di Naxos, Sicily, Italy is to discuss the present - already identified - and the potential new applications in the field of molecular (PET and SPECT) brain imaging (cancer, dementia, behavioural, stroke, and other areas), and to review innovative instrumentation approaches applicable to the advanced brain (and head/neck) imaging.  The symposium is intended as the meeting of instrumentation experts, neuroscientists, and clinicians. We planincluding the subject of novel molecular imaging agents. The following part of the meeting will consist of the talks from speakers-rapporteurs who will provide critical reviews of the PET and SPECT instrumentation issues and discuss the potential solutions  introductory presentations delivered by medical experts in the field of brain imaging, and approaches how to solve them, followed by the representatives of the few selected exemplary brain imaging projects. The major group of participants in the meeting will be the members of the imaging instrumentation community, but the most important participants will be the invited doctors who will be helping the imaging instrumentation experts to understand the real needs and requirements of the brain imaging apparatus to assist in the tasks of detecting, staging and monitoring brain diseases and functional conditions, as well as of the disease treatments.  We will also have representatives of the companies producing dedicated brain imagers, as well as companies producing the detector components and subsystems for the novel compact molecular imagers (PET and SPECT).
With support from